CD4 and neoplasm: Interestingly, we found that CD4+FoxP3+Helios+ Treg subset and CD4+FoxP3−Helios− T cell subset in the tumor microenvironment (TME) contributed differently to the DFS in CRC patients (Fig. 2A, D).